Saltzman, Alexander B.
Chan, Doug W.
Holt, Matthew V.
Wang, Junkai
Jaehnig, Eric J.
Anurag, Meenakshi
Singh, Purba
Malovannaya, Anna
Kim, Beom-Jun
Ellis, Matthew J.
Funding for this research was provided by:
Dan L. Duncan Comprehensive Cancer Center Award (P30 CA125123)
National Cancer Institute (U01CA214125)
CPTAC PGDAC Award (U24 CA210954)
NIH High-End Instrumentation Award (S10 OD026804)
CPRIT Established Investigator Award (RR140033)
CPRIT Core Facility Award (RP170005)
Article History
Received: 30 August 2023
Accepted: 7 December 2023
First Online: 16 January 2024
Declarations
:
: A. Saltzman: None. D. Chan: None. M. Holt: None. J. Wang: None. E. Jaehnig: None. M. Anurag: None. P. Singh: None. A. Malovannaya: None. M. Ellis: None. B. Kim and P. Singh became full-time employees of AstraZeneca and Johnson & Johnson respectively after completion of this study.
: The authors declare that they have no competing interests.